2019 AACR Presentation

We presented a minisymposium talk alongside our collaborators at Genentech called “An in vitro 3D immune exclusion tumor model engineered in a layer-by-layer fashion”, highlighting our platform’s application in creating the immune excluded phenotype with mouse cells and assaying T cell infiltration through our ECM hydrogel, VersaGel®, and subsequent T cell-mediated killing.

Post Contents

Articles From The Same Category

Blogs
Resources

2025 AACR

min read
Resources
Blogs

2024 Antibody Engineering & Therapeutics

min read
Resources
Blogs

2024 AACR Poster

min read

Join Our Newsletter

Lorem ipsum dolor sit amet, consectetur adipiscing elit.

By submitting this form, you agree to receive emails about our products, sales, exclusive content and more. View our Privacy Policy.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

CTA Banner

Lorem ipsum dolor sit amet, consectetur adipiscing elit.

2019 AACR Presentation

We presented a minisymposium talk alongside our collaborators at Genentech called “An in vitro 3D immune exclusion tumor model engineered in a layer-by-layer fashion”, highlighting our platform’s application in creating the immune excluded phenotype with mouse cells and assaying T cell infiltration through our ECM hydrogel, VersaGel®, and subsequent T cell-mediated killing.

Articles from The Same Category

2025 AACR

2024 Antibody Engineering & Therapeutics

2024 AACR Poster

Join Our Newsletter

Lorem ipsum dolor sit amet, consectetur adipiscing elit.

By submitting this form, you agree to receive emails about our products, sales, exclusive content and more. View our Privacy Policy.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

CTA Banner

Lorem ipsum dolor sit amet, consectetur adipiscing elit.